Reverso Therapeutics: Development and In Vivo Validation of Next-Generation Reversable Anticoagulants.

Research unit

INNOSUISSE

Project number

131.499 IP-LS

Project title

Reverso Therapeutics: Development and In Vivo Validation of Next-Generation Reversable Anticoagulants.

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Pharmaceuticals
Abstract (English)	Anticoagulants are life-saving drugs that prevent dangerous blood clots but carry a risk of bleeding. This project will de-risk the development of a new anticoagulant that can be instantly reversed with a simple antidote, making this therapy safer, especially for patients at high risk of bleeding.